The soluble suppression of tumorigenicity-2 protein

1. Prognosis in Heart Failure (HF)

ST2 is a strong independent prognostic marker in both:

• Acute heart failure
• Chronic heart failure
• Higher ST2 levels are associated with:
• Increased mortality
• Higher risk of hospitalization
• Worse overall outcomes

👉 Prognostic value is independent of age, renal function, and ejection fraction.

2. Marker of Myocardial Stress & Fibrosis

ST2 reflects cardiac remodeling and fibrosis, not just hemodynamic overload.

Elevated levels indicate:

• Ongoing myocardial injury
• Adverse ventricular remodeling

This complements natriuretic peptides, which mainly reflect volume/pressure overload.

3. Risk Stratification

Useful for identifying high-risk patients who may benefit from:

• More aggressive therapy
• Closer monitoring and follow-up
• Serial measurements help assess disease progression.

4. Therapy Monitoring

• Falling ST2 levels suggest:
• Effective heart-failure treatment
• Improved prognosis

Rising levels may indicate:

• Treatment failure
• Impending clinical deterioration

5. Acute Cardiovascular Conditions

Elevated ST2 levels are also seen in:

• Acute myocardial infarction
• Acute coronary syndromes
• Cardiogenic shock

In these settings, ST2 correlates with severity and outcomes, rather than diagnosis.

6. Advantages Over Some Other Biomarkers

Not significantly affected by:

• Renal dysfunction
• Obesity
• Age or sex

This makes it particularly useful when BNP/NT-proBNP interpretation is difficult.